Facioscapulohumeral Muscular Dystrophy Type 1 (FSHD1)
2 clinical trials · Condition
◉ Watch Facioscapulohumeral Muscular Dystrophy Type 1 (FSHD1)
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHD (NCT07038200) | Avidity Biosciences, Inc. | 2025-06-10 |
| A Registered Cohort Study on FSHD1 (NCT04369209) | Ning Wang, MD., PhD. | 2001-01-01 |
Track Facioscapulohumeral Muscular Dystrophy Type 1 (FSHD1) automatically
Every clearance here is in the API, with alerts when new ones post.